SVF Endurance (Cayman) Ltd sold $2.9M of Vir Biotechnology (VIR)

Executed Nov 24 2025, disclosed Nov 26 2025, 2 days later.

Value, as filed

$2.9M

463,774 sh across 2 lots

Executed

Nov 24 2025

the trade date, as filed

Disclosed

Nov 26 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SL SVF Endurance (Cayman) Ltd 10% owner profile →

SVF Endurance (Cayman) Ltd (10% owner) filed 6 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 6 sales), most often in VIR. The largest single filing was $2.9M of VIR (524,297 sh across 2 lots, as filed), executed Oct 3 2025.

The name

VIR VIR VIR · 32 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by SVF Endurance (Cayman) Ltd in VIR

VIRSALE Vir Biotechnology, Inc. $1.1M
191,854 sh × $5.98
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. $159K
24,453 sh × $6.50
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. $2.1M
330,210 sh across 2 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. $101K
16,671 sh × $6.07
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. $2.9M
524,297 sh across 2 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 5:30 PM ET